Soleus Capital Management’s Imago BioSciences, Inc. Common stock IMGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-115,000
Closed -$4.13M 104
2022
Q4
$4.13M Sell
115,000
-98,000
-46% -$2.45M 0.59% 43
2022
Q3
$3.21M Buy
+213,000
New +$3.45M 0.44% 51

Soleus Capital Management's IMGO Position: Q1 2023 in Review

Soleus Capital Management sold out of Imago BioSciences, Inc. Common stock (IMGO) in Q1 2023, closing a stake of 115,000 shares — an estimated $4.13M sold.

Soleus Capital Management first reported a position in IMGO in Q3 2022 and held it in 2 quarters. The position peaked at $4.13M in Q4 2022. 0 funds tracked by Wall St. Rank hold IMGO as of Q1 2023.

  • Soleus Capital Management reported no remaining Imago BioSciences, Inc. Common stock position as of Q1 2023 after selling out during the quarter.
  • Soleus Capital Management sold 115,000 Imago BioSciences, Inc. Common stock shares in Q1 2023, an estimated $4.13M.
  • Soleus Capital Management first reported a position in Imago BioSciences, Inc. Common stock in Q3 2022 and held it in 2 quarters.
  • Soleus Capital Management's Imago BioSciences, Inc. Common stock position peaked at $4.13M in Q4 2022.
  • 0 funds tracked by Wall St. Rank held Imago BioSciences, Inc. Common stock as of Q1 2023.

Based on Soleus Capital Management's 13F filing for Q1 2023, filed 15 May 2023.